Reports are starting to filter out that political parties are using AI to their advantage in the upcoming election. Parties are using AI...

Dan M. Berkovitz, Paul Grewal, Jake Chervinsky, Justin Slaughter, and I seem to be aligned on this one, based on this CoinDesk report....

As the internet becomes flooded with AI-generated content, a peculiar set of challenges emerges. One challenge is to humans, with the...

CMS recently announced targeted updates to the ACO REACH Model for PY 2024 on August 15. CMS is attempting to increase predictability for...

McKinsey is now using its own generative AI tool called Lilli. The tool is named after Lillian Dombrowski, the first woman McKinsey hired...

With a virtual tsunami of information and both mature and startup companies targeting AI and health care,  I found this Bain and Co....

FDA has stated the guidance is intended to assist institutional review boards (IRBs), clinical investigators, and sponsors in complying...

OpenAI claims that it has developed a way to use ChatGPT to moderate content. The technique relies on prompting GPT-4 with a policy that...

Navigating AI regulation is a symphony of divergent perspectives. Various players have taken different approaches, with the EU...

I found this interview with Harvard Business School (HBS) professor Karim Lakhani interesting. Here are some highlights: 1. Most...

“Through my questions, you will learn to teach yourselves.”― John Jay Osborn Jr., The Paper Chase This quote from the famous movie, The...

Here's a look at what happens when Washington seeks to regulate Silicon Valley by enforcement. My Bay Area partner Louis Lehot and I...

On August 10, 2023, the U.S. Food & Drug Administration (FDA) published new guidance on obtaining data on underrepresented populations in...

Cosmetic companies are required to submit facility registration and product listing information on cosmetic products that they...

FDA has recently revised Form 356h: Application to Market a New or Abbreviated New Drug or Biologic for Human Use and Form 1571:...

FDA is holding a two-day virtual public workshop to enhance clinical study diversity. This workshop is being held on November 29 and 30,...